Receptor agonism, explained

The Agonists is a small, independent educational website about receptor pharmacology: what full, partial, inverse and biased agonists are, how receptor families differ, and why concepts like efficacy, potency, tolerance and allosteric modulation matter.

Written for students and curious readers. It is not a clinical resource: nothing here is prescribing or dosing advice. Educational information only, not medical advice; consult a qualified professional.

Read the articles About this site

Start here

Full vs. partial agonists

Efficacy, intrinsic activity and why a partial agonist can act like an antagonist.

Inverse agonists

Drugs that reduce a receptor’s constitutive activity below baseline.

Tolerance and desensitization

How receptors adapt to repeated stimulation, from phosphorylation to down-regulation.

Articles

Full Agonists vs Partial Agonists: Understanding Drug Efficacy
The distinction between full and partial agonists is fundamental to pharmacology. Learn how intrinsic efficacy determines a drug's maximal response an

Inverse Agonists: Drugs That Do the Opposite
Inverse agonists bind receptors and reduce activity below basal levels — a pharmacological concept that challenges traditional agonist/antagonist thin

Beta-2 Agonists in Asthma Treatment
Beta-2 agonists are among the most widely used drugs in medicine, forming the backbone of asthma and COPD management. Learn how they relax airways and

Opioid Agonists and the Analgesic Effect
Opioid agonists are the most powerful analgesics available, but their pharmacology is complex and their risks are substantial. This guide explains how

Receptor Desensitization and Drug Tolerance Mechanisms
Drug tolerance — when a drug becomes less effective with repeated use — is rooted in receptor desensitization and downregulation. Understanding these

Allosteric Modulators: Shaping Receptor Function Without Direct Activation
Allosteric modulators bind to receptor sites distinct from the orthosteric binding site, changing receptor conformation and modifying agonist response

All articles →

Types of Receptor Agonists

Understanding the spectrum of agonist activity, from full activation to constitutive receptor modulation.

Full Agonist

Produces maximal response (Emax) by fully stabilizing the active receptor conformation. Examples: morphine (mu-opioid), isoproterenol (beta-adrenergic).

Partial Agonist

Produces sub-maximal response even at saturating concentrations. Can act as functional antagonist in presence of full agonist. Examples: buprenorphine, aripiprazole.

Inverse Agonist

Reduces constitutive receptor activity below basal levels. Stabilizes inactive conformation. Examples: famotidine (H2), rimonabant (CB1).

Biased Agonist

Selectively activates one signaling pathway over another at the same receptor. Examples: oliceridine (mu-opioid, G-protein biased).

Receptor Pharmacology

Major receptor superfamilies and their agonist pharmacology in drug development.

G Protein-Coupled Receptors

The largest superfamily of drug targets. GPCRs transduce extracellular signals through heterotrimeric G proteins and beta-arrestin pathways. Over 30% of FDA-approved drugs target GPCRs.

Ligand-Gated Ion Channels

Ionotropic receptors (nAChR, GABA-A, NMDA, 5-HT3) open ion channels upon agonist binding. Sub-millisecond signaling critical in neurotransmission.

Nuclear Receptors

Intracellular receptors (estrogen, thyroid, glucocorticoid, PPAR) bind lipophilic agonists that cross the membrane, directly modulating gene transcription.

Receptor Tyrosine Kinases

Growth factor receptors (EGFR, VEGFR, PDGFR) activated by dimerization. Downstream MAPK/PI3K cascades drive proliferation. Key targets in oncology.

Allosteric Modulators

Positive allosteric modulators (PAMs) enhance agonist response without occupying the orthosteric site. Benzodiazepines at GABA-A exemplify this pharmacology.

Dose-Response Analysis

EC50, Hill coefficient, efficacy vs potency, Schild analysis, and operational models quantify agonist activity for drug candidate selection.

Educational information only, not medical advice; consult a qualified professional. Drug names are mentioned to illustrate pharmacological concepts, not as treatment recommendations.

Loading latest news...